Demand For Abbott Labs Covid-19 Tests Eclipses 100 Million As Pandemic Rages On

Demand for Abbott Laboratories’ portfolio of tests for Covid-19 is surging around the world as the pandemic rages on, the company said Wednesday.

Abbott, which sells an array of established drugs, medical devices for people with diabetes and diagnostics, said Covid-19 diagnostic-testing related sales were $881 million of the company’s global sales of $8.9 billion, the company said in its third quarter earnings report.